Published in N Engl J Med on January 07, 1971
Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia. J Clin Invest (1971) 4.98
DTT test: a new method to differentiate IgM and IgG erythrocyte antibodies. Vox Sang (1974) 1.59
Immune haemolytic disease: the autoimmune haemolytic anaemias. Clin Haematol (1975) 1.56
IgD: a major immunoglobulin on the surface of lymphocytes from patients with chronic lymphatic leukemia. J Immunol (1974) 1.56
The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest (1972) 1.50
Intravenous immunoglobulin therapy for antibody deficiency. Clin Exp Immunol (1979) 1.36
The prognostic and therapeutic implications of DNA:anti-DNA immune complexes in systemic lupus erythematosus (SLE). Am J Med (1975) 1.30
Digital ischemia and gangrene preceding renal neoplasm. An association with sarcomatoid adenocarcinoma of the kidney. Arch Intern Med (1976) 1.14
Individual patient variations in the kinetics of intravenous immune globulin administration. J Clin Immunol (1982) 1.10
Lupus meningitis. Antibody to deoxyribonucleic acid (DNA) and DNA:anti-DNA complexes in cerebrospinal fluid. Ann Intern Med (1974) 1.10
Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. Science (1982) 1.04
Intravenous immune globulin therapy in hypogammaglobulinemia. A review. Am J Med (1984) 1.03
Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states. Am J Med (1984) 0.99
Antilymphocyte antisera in immunologically mediated renal disease. JAMA (1969) 0.99
Clinical aspects of autoimmune hemolytic anemia. Semin Hematol (1976) 0.98
Addisonian pernicious anemia with positive antiglobulin tests. A multiple autoimmune disease syndrome. Am J Clin Pathol (1968) 0.98
Home-based immunoglobulin infusion therapy: quality of life and patient health perceptions. Ann Allergy (1991) 0.95
Autoimmune hemolytic anemia and neoplasia of the reticuloendothelium. With a hypothesis concerning etiologic relationships. Ann Intern Med (1968) 0.95
Autoimmune hemolytic anemia and ulcerative colitis: a multisystem immunodeficiency disease? Int Arch Allergy Appl Immunol (1970) 0.95
Safety and patient acceptability of intravenous immune globulin in 10% maltose. Lancet (1980) 0.91
Diet-induced systemic lupus erythematosus (SLE) in primates. Am J Kidney Dis (1982) 0.87
Clinical and bronchial provocation studies in patients with meatwrappers' asthma. J Allergy Clin Immunol (1976) 0.85
Hereditary aspects of autoimmune hemolytic anemia; a retrospective analysis. Vox Sang (1968) 0.85
Clinical studies on the significance of DNA:anti-DNA complexes in the systemic circulation and cerebrospinal fluid (CSF) of patients with systemic lupus erythematosus. J Rheumatol (1975) 0.84
Immunosuppressive therapy for severe chronic uveitis. Arch Ophthalmol (1978) 0.84
Immunosuppressive therapy in rheumatic disease. Med Clin North Am (1977) 0.83
Antigen heterogeneity of human B and T lymphocytes. J Clin Invest (1976) 0.83
"Foreign serum" heterophile antibodies in patients receiving antithymocyte antisera. Blood (1973) 0.82
Heparin sensitivity. Report of a case. Arch Intern Med (1973) 0.80
The effect of oxisuran on human immunological responsiveness. Transplantation (1975) 0.79
Cellular immune competence in the human fetus. Cell Immunol (1973) 0.79
Antithymocyte antisera theapy in nonsurgical immunologic disease. Transplant Proc (1971) 0.78
Prospective study on the hepatitis safety of intravenous immunoglobulin, pH 4.25. Vox Sang (1991) 0.78
Non-A non-B hepatitis and the safety of intravenous immune globulin, pH 4.2: a retrospective survey. Preliminary communication. Vox Sang (1988) 0.77
Positive antiglobulin reactions complicating urological surgery. J Urol (1966) 0.77
Silent renal involvement in systemic lupus erythematosus. Int Arch Allergy Appl Immunol (1977) 0.77
Myasthenia gravis treated with purified antithymocyte antiserum. Neurology (1979) 0.76
Synergistic immunosuppressive action of antithymocyte antisera and thymectomy in the human. Clin Exp Immunol (1972) 0.75
Recent advances in the immunopathogenesis of systemic lupus erythematosus. West J Med (1975) 0.75
Inhibition of lymphocyte growth by Ulex seed extracts (USE). Immunology (1981) 0.75
Azathioprine in steroid-insensitive nephropathy. Am J Med (1970) 0.75
Immunologic aspects of malignancy. Am J Obstet Gynecol (1978) 0.75
Heparin as treatment for bronchospasm of asthma. Ann Allergy (1969) 0.75
Immunosuppressive therapy of severe chronic uveitis. Trans Pac Coast Otoophthalmol Soc Annu Meet (1976) 0.75
Hyperacute renal allograft rejection in the human neonate. Invest Urol (1973) 0.75
Immunologic aspects of the maternal-fetal state. Ann Allergy (1966) 0.75
Ulex seed extracts: lymphocyte growth inhibition and the anti-H hemagglutinins. Vox Sang (1982) 0.75
Production of immune tolerance in humans. Nature (1968) 0.75
The antigen in autoimmune hemolytic anemia. I. Reactivity of human autoantibodies and rhesus antibodies with primate and non-primate erythrocytes. Am J Clin Pathol (1966) 0.75
Antithymocyte antisera globulin effect on human lymphoid neoplasia. Arch Intern Med (1973) 0.75
Immunologic studies of human plasma cells. Am J Hematol (1976) 0.75
Profile of Edwin E. Osgood, M. D. Blood (1969) 0.75
The use of heparin in autoimmune hemolytic disease. Blood (1970) 0.75
The influence of immunosuppression and allografting on virus-induced lymphatic leukemia in mice. Transplantation (1972) 0.75
Antilymphocyte antiserum effect on incidence of spontaneous malignancy. I. Long term treated mice. Postgrad Med J (1976) 0.75
The influence of dialysis in 2-mercaptoethanol reduction of erythrocyte antibodies. Transfusion (1974) 0.75
Antithymocyte antiserum therapy in myasthenia gravis. Postgrad Med J (1976) 0.75
Prediction of intrauterine fetal involvement in erythroblastosis fetalis. Comparative analysis of prediction with immune antibody titers and amniotic fluid analyses. Obstet Gynecol (1967) 0.75
Lack of oncogenicity with immunosuppressive therapy. Cancer (1980) 0.75
Autoimmune hemolytic anemia. I. Clinical aspects. Ser Haematol (1974) 0.75
Macroglobulinemia with positive antiglobulin tests. Transfusion (1971) 0.75
The effect of anti-thymocyte antiserum in progressive myasthenia gravis. Ann N Y Acad Sci (1981) 0.75
Mechanism of the mitogenic action of the Phytohemagglutinin. I. Induction of tolerance and lymphocyte transformation. J Reticuloendothel Soc (1973) 0.75
When autoimmune hemolytic anemia complicates chronic lymphocytic leukemia. Geriatrics (1978) 0.75
Autoimmune hemolytic anemia. II. Therapeutic aspects. Ser Haematol (1974) 0.75
Antithymocyte antiserum effects in man. Am J Med (1974) 0.75
[Studies in man on acquired immunologic tolerance]. Gac Med Mex (1968) 0.75
Safety and toxicity of a new serum immunoglobulin G intravenous preparation, IGIV pH 4.25. Rev Infect Dis (1986) 0.75
Immunologic aspects of malignancy. Trans Pac Coast Obstet Gynecol Soc (1978) 0.75
Noncytotoxic inhibition of malignant cell growth by Ulex seed extracts. J Biol Response Mod (1983) 0.75
The structure and specificity of erythrocyte autoantibodies. Ann N Y Acad Sci (1965) 0.75